Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea
· Delayed Price · Currency is KRW 5,990.00
-100.00 (-1.64%)
At close: Mar 9, 2026
Sinil Pharmaceutical Revenue
Sinil Pharmaceutical had revenue of 20.62B KRW in the quarter ending September 30, 2025, a decrease of -0.03%. This brings the company's revenue in the last twelve months to 80.97B, down -11.70% year-over-year. In the year 2024, Sinil Pharmaceutical had annual revenue of 89.44B with 0.34% growth.
Revenue (ttm)
80.97B
Revenue Growth
-11.70%
P/S Ratio
0.84
Revenue / Employee
282.13M
Employees
287
Market Cap
68.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 89.44B | 305.25M | 0.34% |
| Dec 31, 2023 | 89.14B | 9.13B | 11.41% |
| Dec 31, 2022 | 80.01B | 18.25B | 29.56% |
| Dec 31, 2021 | 61.75B | 316.13M | 0.51% |
| Dec 31, 2020 | 61.44B | 789.70M | 1.30% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmax Nbt | 293.75B |
| Optipharm.CO.,LTD | 21.98B |
| Jin Yang Pharmaceutical | 117.19B |
| BL Pharmtech | 6.98B |
| RP Bio | 134.21B |
| Polaris AI Pharma | 63.94B |
| GL Pharm Tech | 34.30B |
| Hwail Pharmaceutical | 107.87B |